Skip to content

Clinical trials

Carcinoma, Medullary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Medullary Clear all

141 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20021
20035
20046
20054
20067
20073
20084
20091
20105
20112
201211
20134
20145
20157
20162
20176
20186
20195
20205
20218
20223
20236
20244
20258
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed65
Active, not recruiting17
Unknown status13
Terminated12
Recruiting11
Not yet recruiting10
Withdrawn6
Enrolling by invitation3
Approved for marketing3
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)20
M.D. Anderson Cancer Center7
Genzyme, a Sanofi Company6
Eli Lilly and Company4
Exelixis4
Cancer Institute and Hospital, Chinese Academy of Medical Sciences3
European Organisation for Research and Treatment of Cancer - EORTC3
Jonsson Comprehensive Cancer Center3
Sanofi3
University of Pennsylvania3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Medullary141
Thyroid Neoplasms49
Thyroid Cancer, Papillary27
Adenocarcinoma, Follicular21
Carcinoma, Non-Small-Cell Lung20
Head and Neck Neoplasms20
Thyroid Carcinoma, Anaplastic19
Colonic Neoplasms15
Pheochromocytoma15
Breast Neoplasms13

Trials

Showing 51 to 75 of 141. Each trial links to its page on Pharma Observatory.

41 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.